Wenling Zhang

6PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyPredictive and prognostic markersMolecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 25, 2024
Inhibin subunit beta B (INHBB): an emerging role in tumor progression.

Ying Liu, Qing Zhou, Guoying Zou

|Jan 05, 2024
Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics.

Shiqi Yan, Yilin Guo, Lizhong Lin

|Jun 26, 2023
The immune escape mechanism of nasopharyngeal carcinoma.

Xiaoxu Li, Yinlin Guo, Minmin Xiao

|Dec 23, 2022
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer.

Ritu Arora, Jin-Hwan Kim, Ayechew A Getu

|Jun 09, 2022
NUCB2: roles in physiology and pathology.

Qing Zhou, Ying Liu, Ranran Feng

|Jul 23, 2020
Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.

Yijun Liu, Qingluan Liu, Zhicheng Wang

Pageof 1